Additionally, from 8 reported markers reflecting B-cell level in tumor environment, some of them, such as PNOC, FCRL2, CD19, were found to have different degrees of impact on poorer prognosis on overall survival of ccRCC cohort (Supplementary Figure 1A). The gene discussed is FCRL2; the disease is nonpapillary renal cell carcinoma.